Stock Market & Financial Investment News

News Breaks December 21, 2012 09:04 EDT ALXA FDA PDUFA Date for Adasuve The FDA assigned a Prescription Drug User Fee Act (PDUFA) action date for Alexza Pharmaceuticals' New Drug Application (NDA) for ADASUVE for treatment of agitation associated with schizophrenia or bipolar disorder in adults of December 21. 2012. News For ALXA From The Last 14 Days Check below for free stories on ALXA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 16:23 EDT ALXA Alexza Pharmaceuticals chief commercial officer to leave company Subscribe for More Information May 14, 2013 16:13 EDT ALXA Alexza Pharmaceuticals reports Q1 EPS ($1.31), consensus (45c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.